Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Suh, Cheolwon  [Clear All Filters]
2023
Kim SJin, Jo J-C, Yoon DHyun, Yang D-H, Yoon SEun, Lee G-W, Kong JHyun, Park Y, Kang K-W, Lee H-S, et al. Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation. Front Oncol. 2023;13:1230629.
Cho H, Yoon DHyun, Shin D-Y, Koh Y, Yoon S-S, Kim SJin, Do YRok, Lee G-W, Kwak J-Y, Park Y, et al. Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404). Cancer Res Treat. 2023.
2022
Yi JHo, Jeong SHyun, Kim SJin, Yoon DHyun, Kang HJin, Koh Y, Kim JSeok, Lee W-S, Yang D-H, Do YRok, et al. Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts. Cancer Res Treat. 2022.
2020
Kang J, Chae H, Hong JYong, Yoon DHyun, Kim S, Park JSun, Lee SWook, Park CSik, Ryu J-S, Huh J, et al. Distinct clinical characteristics at diagnosis in patients with late relapses compared with early relapses of diffuse large B-cell lymphoma treated with R-CHOP. Leuk Lymphoma. 2020:1-7.
Kim KHa, Kim WSeog, Kim SJin, Yoon DHyun, Suh C, Kang HJin, Choi CWon, Lee HSup, Bae SHwa, Park J, et al. Treatment with Intravenous Busulfan, Melphalan, and Etoposide (BuME) followed by Autologous Stem Cell Transplantation in Patients with Non-Hodgkin's Lymphoma: A Multicenter Study from the Consortium for Improving Survival of Lymphoma (CISL). Transpl Int. 2020.
2014
Jang I-Y, Yoon DHyun, Kim S, Lee K, Kim K-K, Lim Y-M, Min W-K, Suh C. Advanced POEMS syndrome treated with high-dose melphalan followed by autologous blood stem cell transplantation: a single-center experience. Blood Res. 2014;49(1):42-8.
2013
Jo J-C, Yoon DHyun, Kim S, Lee K, Kang EHee, Jang S, Park C-J, Chi H-S, Huh J, Park C-S, et al. Clinical significance of the appearance of abnormal protein band in patients with multiple myeloma. Ann Hematol. 2013.
Ohmachi K, Niitsu N, Uchida T, Kim SJin, Ando K, Takahashi N, Takahashi N, Uike N, Eom HSeok, Chae YSoo, et al. Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma. J Clin Oncol. 2013.
Kim SJin, Yoon DHyun, Yang D-H, Eom HSeok, Cho SGoo, Yoon S-S, Lee JHoon, Kim WSeog, Suh C. Plerixafor use for peripheral blood stem cell mobilization in Korea. Blood Res. 2013;48(2):72-3.